1 55550sek
-1,0 %
Date:2026-09-04Time:17:29:47Latest report:Q2-2026List:Large CapTicker:AZN
Market Cap:2 412 648 msekEnterprise Value:2 673 715 msekNet Sales:61 366 musdEarnings:10 446 musdEmployees:0ISIN:GB0009895292

Ratios

10-year key figure history for AstraZeneca turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for AstraZeneca with index and moving average MA50 and MA200.

Stockprice:1 555,50
MA50:1 625,82
MA200:1 719,44
Price/MA200:-9,5 %
RSI (14):45,9
Price/MA50:-4,3 %

Description

AstraZeneca is a global pharmaceutical company focused on the research, development and marketing of prescription medicines, primarily for the treatment of diseases in the therapeutic areas of respiratory, cardiovascular/metabolic and cancer. In addition to its core business, the company also has a focus on the areas of autoimmunity, neuroscience and infection. AstraZeneca operates in all global regions and is headquartered in Cambridge, UK.